Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.600 Biomarker disease MGD
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.600 GeneticVariation disease BEFREE The present results demonstrated a higher participation of Ki-ras gene mutations in EHC than found in previous studies, and provided a confirmation and extension of the results earlier reported by Tada et al. and Tsuda et al. for IHC. 7830335 1994
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.010 GeneticVariation disease BEFREE The present results demonstrated a higher participation of Ki-ras gene mutations in EHC than found in previous studies, and provided a confirmation and extension of the results earlier reported by Tada et al. and Tsuda et al. for IHC. 7830335 1994
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation disease BEFREE Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology. 7557145 1995
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.600 Biomarker disease CTD_human Histogenesis and the role of p53 and K-ras mutations in hepatocarcinogenesis by glyceryl trinitrate (nitroglycerin) in male F344 rats. 8968066 1996
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker disease BEFREE We investigated mutations of the RAS and the TP53 genes in archival sections of ICC induced by Thorotrast. 10564951 1999
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.600 Biomarker disease BEFREE To analyze the molecular carcinogenesis of ICC, we examined the alterations of the p53, APC, and K-ras genes in 40 surgically resected ICC cases. 10212000 1999
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation disease BEFREE These data suggest that each of the examined genes is involved in the development of ICC and that the p53 and K-ras mutation may play a role in the tumor growth pattern. 10212000 1999
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation disease BEFREE In addition, point mutations of ras and p53 were examined genetically in selected ICC cases by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and direct sequence analysis. 10469215 1999
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.600 GeneticVariation disease BEFREE Compared to ICC that was not associated with Thorotrast, the frequency of mutation of the KRAS gene was lower, while that of the TP53 gene was more than two times higher. 10564951 1999
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
0.050 Biomarker disease BEFREE We examined immunohistochemically ras p21 protein and p53-related products (p53 protein, WAF-1 and mdm-2) in 43 cases of ICC. 10469215 1999
Entrez Id: 1026
Gene Symbol: CDKN1A
CDKN1A
0.020 Biomarker disease BEFREE We examined immunohistochemically ras p21 protein and p53-related products (p53 protein, WAF-1 and mdm-2) in 43 cases of ICC. 10469215 1999
Entrez Id: 7011
Gene Symbol: TEP1
TEP1
0.010 AlteredExpression disease BEFREE There was no correlation between histological subtype of ICC and expression of hTR and TP1 mRNA. 10498642 1999
Entrez Id: 324
Gene Symbol: APC
APC
0.010 GeneticVariation disease BEFREE Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma. 10212000 1999
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 AlteredExpression disease BEFREE Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features. 10963376 2000
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 GeneticVariation disease BEFREE The systematic screening for p53 mutations in European patients with hilar cholangiocarcinoma has shown that the type of mutation (except 175) is different and its incidence is much lower when compared to the pattern previously reported for intrahepatic cholangiocarcinoma in East Asian patients. 10998080 2000
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.600 Biomarker disease BEFREE In conclusion, we show that 1 putative tumor-suppressor gene on 8p22 may relate to progression of ICC and suggest that the p53 tumor-suppressor gene may be associated with carcinogenesis of ICC. 11004673 2000
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.050 GeneticVariation disease BEFREE To investigate the tumour suppressor gene p16 and its possible association with K-ras mutations in intrahepatic cholangiocarcinomas of the liver. 11034592 2000
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
0.050 AlteredExpression disease BEFREE There was no significant difference between the MDM2 overexpression and ICC tumor grade. 10963376 2000
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.010 GeneticVariation disease BEFREE To investigate the tumour suppressor gene p16 and its possible association with K-ras mutations in intrahepatic cholangiocarcinomas of the liver. 11034592 2000
Entrez Id: 9260
Gene Symbol: PDLIM7
PDLIM7
0.010 Biomarker disease BEFREE To determine whether EBV is commonly involved in the developments of ICC, we performed in-situ hybridization and immunohistochemistry for EBV in 215 cases of ICC in Japan, using a probe against EBV-coded nuclear RNA (EBER) and a specific antibody against latent membrane protein-1 (LMP-1), respectively. 10632752 2000
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
0.050 Biomarker disease BEFREE We studied the incidence of microsatellite instability (MSI) involving eight highly polymorphic microsatellite markers and alternations of the K-ras, p53 and mdm-2 genes in human ICC tissues. 11580146 2001
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.050 Biomarker disease BEFREE Mutations in beta-catenin exon 3 do not appear to be responsible for nuclear translocation of beta-catenin in ICCs. 11557787 2001
Entrez Id: 595
Gene Symbol: CCND1
CCND1
0.050 GeneticVariation disease BEFREE Of those five cases of ICC, all had poor histological differentiation, and four of the five ICCs (80%) showed evidence of cyclin D1 immunoreactivity. 11495045 2001
Entrez Id: 4582
Gene Symbol: MUC1
MUC1
0.050 Biomarker disease BEFREE A high level expression of MUC1 mucins with sialylated carbohydrates (sialylated MUC1 mucins) is correlated with poor survival in intrahepatic bile duct carcinoma. 11350903 2001